After prostate cancer treatment, a new standard of care for rising PSA

When prostate cancer recurs after initial treatment, doctors typically treat it with hormonal therapies. But results from a large clinical trial show that a different medication (or combination of two medications) is a better approach.

Content restricted. Requires subscription